US drug approvals
3 approvals with a product on the US market
- Azacitidine ANDA212580 · approved 16 May 2024
- Lacosamide ANDA204921 · approved 17 Mar 2022
- Ubrogepant ANDA219218
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.